Single Arm Phase II Study to Assess the Efficacy of Pembrolizumab Plus Radiotherapy or Ablation in Metastatic Colorectal Cancer Patients
Phase of Trial: Phase II
Latest Information Update: 30 Jun 2017
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 21 Jun 2017 Planned End Date changed from 1 Apr 2017 to 1 Apr 2018.
- 21 Jun 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Apr 2018.
- 12 May 2015 New trial record